piribedil has been researched along with Dementia in 2 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oules, MJ | 1 |
| Boscredon, J | 1 |
| Scholing, WE | 1 |
| Clausen, HD | 1 |
1 trial available for piribedil and Dementia
| Article | Year |
|---|---|
[Psychological studies of a long-term treatment of the neurovascular syndrom with Trivastal (author's tranls)].
Topics: Aged; Analysis of Variance; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical | 1975 |
1 other study available for piribedil and Dementia
| Article | Year |
|---|---|
[Clinical study of cerebral dopaminergic mechanisms: the action of piribedil in psychiatry. Initial results].
Topics: Adjustment Disorders; Aged; Dementia; Depression; Humans; Middle Aged; Piperazines; Piribedil | 1979 |